A model to predict survival in patients with end-stage liver disease. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. Systematic review: the model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?. 2002 36:494-500.Ĭholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Transection of the oesophagus for bleeding oesophageal varices. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. MELD score is superior to the CTP score to predict mortality in patients. Updates to NLRB guidance for pediatric candidates. Revised qualification criteria for pediatric Status 1A and 1B candidates. The changes include: Updates to calculation of both the MELD and PELD formulas. 4 A study including 140 patients undergoing TIPS showed that the MELD was more accurate than the CTP score for predicting three-month mortality. The MELD score is continuous, with 34 levels ranging between 6 and 40. A set of improvements to MELD, PELD, Status 1A and 1B is in effect as of July 13, 2023. The study showed: (1) the MELD, the CTP score, and the Emory score were similar in accuracy for predicting three-month mortality (2) the MELD was more accurate than the others for predicting 12-month mortality and (3) the MELD and the CTP score were more accurate than the Emory score for predicting 36-month mortality. The accuracy of each score was measured using the concordance-statistic (c-statistic): 1 was a score that perfectly predicted the outcome in question, and 0 was a score that failed to predict any outcome correctly. The mean age of patients was 57 years, about two thirds were men, and most had alcoholic cirrhosis. 4 The study used the version of the MELD that included creatinine, bilirubin, INR, and cause of cirrhosis. doi:10.1038/s4139-9.A German study compared the MELD, the CTP score, and the Emory score in predicting the prognosis of 162 patients with end-stage liver disease who were undergoing transjugular intrahepatic portosystemic shunting (TIPS). On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis. Yip TC, Chan HL, Tse YK, Lam KL, Lui GC, Wong VW, et al. University of Wisconsin School of Medicine and Public Health. Model for End-stage Liver Disease (MELD) score and liver transplant: benefits and concerns. doi:10.2147/CEG.S160537Īiello FI, Bajo M, Marti F, Gadano A, Musso CG. Liver function tests in identifying patients with liver disease. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values. Johnson SA, Vazquez SR, Fleming R, Lanspa MJ. This topic will review the use, impact, refinements, and limitations of the MELD score, particularly with regard to its use in allocating organs. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. The MELD calculator is for transplant candidates whose current age is at least 12 years old. Models that are used commonly in the care of patients with cirrhosis are the Child-Turcotte-Pugh score, the Model for End-stage Liver Disease (MELD) score, and the MELD-Sodium (MELD-Na) score 2-6. The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Zaydfudim VM, Turrentine FE, Smolkin ME, et al. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. Important predictor of mortality in patients with end-stage liver disease. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |